Search results for NEDD8 Antibody

Anti-NEDD8 Antibody (R2G73), AntibodySystem, RHH21701

NEDD8 (NEDD8) Antibody (Biotin), Abbexa, abx346073

NEDD8 (NEDD8) Antibody (Biotin) is a Rabbit Polyclonal antibody conjugated to Biotin for the detection of Human NEDD8.

NEDD8 (NEDD8) Antibody (FITC), Abbexa, abx346072

NEDD8 (NEDD8) Antibody (FITC) is a Rabbit Polyclonal antibody conjugated to FITC for the detection of Human NEDD8.

Anti-NEDD8 Antibody (R3U13), AntibodySystem, RHH21703

Anti-NEDD8 Antibody (R3U14), AntibodySystem, RHH21702

NEDD8 (NEDD8) Antibody (HRP), Abbexa, abx346071

NEDD8 (NEDD8) Antibody (HRP) is a Rabbit Polyclonal antibody conjugated to HRP for the detection of Human NEDD8.

PE Anti-NEDD8 antibody [Y297], Abcam, AB305725

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

NEDD8 Antibody (YA4303)(PBS only), MedChemexpress, HY-P84606A

NEDD8 Antibody (YA4303) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to NEDD8.

APC Anti-NEDD8 antibody [Y297], Abcam, AB305726

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

HRP Anti-NEDD8 antibody [Y297], Abcam, AB305727

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .